Navigation Links
Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors
Date:12/14/2009

FREMONT, Calif., Dec. 14 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Pink Sheets: VRML), a molecular diagnostics company, today announced William C. Wallen, Ph.D. Chief Scientific Officer, Senior Vice President, Research and Development for IDEXX Laboratories, will be joining its board of directors upon confirmation of Vermillion's bankruptcy plan.

"Bill brings more than 20 years research and development experience in diagnostics and biotechnology," said Gail Page, Vermillion Executive Chairperson. "His broad knowledge of product development and particularly biomarkers will be invaluable to Vermillion as we both market OVA1 and more fully develop our biomarker product pipeline."

Prior to joining IDEXX Laboratories, Dr. Wallen held a number of high level positions with Bayer Healthcare, Diagnostics Division achieving the position of Senior Vice President, Head Officer of Technology. He previously held leadership roles at Becton Dickenson and Wampole Laboratories, a division of Carter-Wallace, Inc. Dr. Wallen received his Bachelor and Masters of Science from Michigan State University and his Ph.D. in Molecular Biology from University of Arizona College of Medicine.

He is a member of the American Association of Clinical Chemistry, the American Society for Microbiology, American Association for Cancer Research, The Leukemia society of America, and the New York Academy of Science. He has published 55 papers.

"We are thrilled that someone with Dr. Wallen's stature and expertise has selected Vermillion to be the company on whose Board he wishes to sit," said Page.

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... On April 19th the Center ... search for the growing antibiotic resistant bacteria that may ... year long study were released late last month showing ... over previous years. For those suffering from bacteria driven ... resistant bacteria in food, may eventually help breed acne ...
(Date:5/23/2013)... SOUTH EASTON, Mass. , May 23, 2013 /PRNewswire/ ... "Company") today announced that the Company will host a ... and to provide a business update. The teleconference information ... 2013 Time: 11:00 a.m. Eastern Daylight Time (EDT) ... Canada ); (302) 607-2001 (Int,l) Passcode: VS22823 ...
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ... only FDA, Health Canada and CE (Europe) approved Total ... in Scotland, which boasts more than 380,000 visitors annually, ... powered by the Freedom® portable driver as part ... most advanced exhibitions of its kind. , “BodyWorks ...
(Date:5/23/2013)... 2013 Watlow®, an industry leader ... systems, recently introduced its new catalog, Watlow® Heating ... in designing and manufacturing industrial heaters, Watlow provides ... serve diverse customer needs. , A description of ... beginning of the book. These options allow high ...
Breaking Biology Technology:Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3Watlow Introduces Its New Industrial Heater Catalog 2
... 2011 Orexigen ® Therapeutics, Inc. (Nasdaq: ... on the treatment of obesity, today announced that ... Morgan Healthcare Conference. The details are as follows: ... Pacific TimeLocation:  Westin St. Francis Hotel, San Francisco, ...
... Group, Inc. (OTC Bulletin Board: BONU ), ... has received correspondence from KHA Solutions Group following a ... Group, a for-profit entity and a wholly owned subsidiary ... into BioNeutral and its products, BioNeutral may be selected ...
... 2011 Cellular Dynamics International, Inc. (CDI), the world,s ... lines and tissue cells for drug discovery and safety, ... at the 29th Annual JPMorgan Healthcare Conference at 7:30 ... Francis Hotel in San Francisco. Robert Palay, chief executive ...
Cached Biology Technology:Kentucky Hospital Association Solutions Group Outlines Next Steps for BioNeutral Partnership 2Kentucky Hospital Association Solutions Group Outlines Next Steps for BioNeutral Partnership 3
(Date:5/23/2013)... Rollins School of Public Health at Emory University, ... Technology, have received a $4 million grant over ... Emory University (Health and Exposome Research Center: Understanding ... center grant awarded in the United States. ... National Institute of Environmental Health Sciences (NIEHS) of ...
(Date:5/23/2013)... wrapping of genomic DNA around nucleosomes in the ... A team of Ludwig-Maximilians-Universitaet (LMU) in Munich now ... be locally displaced from nucleosomes for transcription. , ... in the cell nucleus, wrapped around disk-shaped particles ... four different histone proteins and accommodating two loops ...
(Date:5/23/2013)... undergo surgery or harsh treatments because science fails ... forms of the disease. Researchers at Case Western ... developing technology that allows patients to safely choose ... or take drastic measures. , The project is ... of biomedical engineering at Case Western Reserve and ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Biochemistry: Unspooling DNA from nucleosomal disks 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
... December 2, 2010 -- Intense, individually tailored dietary treatment ... mortality, according to a new study by researchers at ... just published in the prestigious Journal of the ... months after discharge (11.6 percent) of the control group ...
... year, dengue fever infects as many as 100 million people ... Both diseases are spread by infected female Aedes ... The blood feeding and the egg development are tightly linked ... a team of entomologists at the University of California, Riverside ...
... cited Pfeiffer,s research in biomedical imaging, and in particular ... approach has laid the foundation for applications of this ... to deliver improved image contrast with lower doses of ... from fundamental biophysical investigations to applications in medical imaging ...
Cached Biology News:Personalized diets for elderly after hospitalization decreases mortality rates 2Discovery by UC Riverside entomologists could shrink dengue-spreading mosquito population 2Physicist Franz Pfeiffer receives 2011 Leibniz Prize 2